Equity Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2017 |
| Equity Compensation |
|
| Summary of stock option activity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
Shares Subject
|
|
Weighted
|
|
Remaining
|
|
|
|
|
to Options
|
|
Average
|
|
Contractual
|
|
|
|
|
Outstanding
|
|
Exercise Price
|
|
Life (Years)
|
|
|
Balance at December 31, 2016
|
|
3,776,405
|
|
|
11.55
|
|
|
|
|
Exercised
|
|
(873,523)
|
|
|
8.90
|
|
|
|
|
Expired
|
|
(54,401)
|
|
|
17.52
|
|
|
|
|
Forfeited
|
|
(23,670)
|
|
|
16.73
|
|
|
|
|
Balance at June 30, 2017
|
|
2,824,811
|
|
|
12.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable options at June 30, 2017
|
|
2,356,503
|
|
|
11.73
|
|
5.4
|
|
|
Vested and expected to vest at June 30, 2017
|
|
2,824,811
|
|
|
12.20
|
|
5.7
|
|
|
| Summary of stock options outstanding and exercisable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
|
|
Shares Subject
|
|
Weighted
|
|
Remaining
|
|
|
|
|
to Options
|
|
Average
|
|
Contractual
|
|
|
|
|
Outstanding
|
|
Exercise Price
|
|
Life (Years)
|
|
|
Balance at December 31, 2016
|
|
3,776,405
|
|
|
11.55
|
|
|
|
|
Exercised
|
|
(873,523)
|
|
|
8.90
|
|
|
|
|
Expired
|
|
(54,401)
|
|
|
17.52
|
|
|
|
|
Forfeited
|
|
(23,670)
|
|
|
16.73
|
|
|
|
|
Balance at June 30, 2017
|
|
2,824,811
|
|
|
12.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable options at June 30, 2017
|
|
2,356,503
|
|
|
11.73
|
|
5.4
|
|
|
Vested and expected to vest at June 30, 2017
|
|
2,824,811
|
|
|
12.20
|
|
5.7
|
|
The following table summarizes information about stock options outstanding and exercisable at June 30, 2017:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
Options Exercisable
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
|
|
|
|
Weighted-
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
Average
|
|
|
|
Average
|
|
|
|
|
|
|
|
Average
|
|
Number of
|
|
Remaining
|
|
Number of
|
|
Remaining
|
|
|
|
|
|
|
|
Exercise
|
|
Underlying
|
|
Contractual
|
|
Underlying
|
|
Contractual
|
|
|
Range of Exercise Prices
|
|
Price
|
|
Shares
|
|
Life (in years)
|
|
Shares
|
|
Life (in years)
|
|
|
$
|
3.59
|
-
|
6.14
|
|
|
5.97
|
|
904,662
|
|
3.9
|
|
904,662
|
|
3.9
|
|
|
$
|
6.34
|
-
|
9.93
|
|
|
8.45
|
|
391,363
|
|
6.0
|
|
310,753
|
|
5.3
|
|
|
$
|
11.28
|
-
|
16.97
|
|
|
13.91
|
|
892,486
|
|
6.8
|
|
605,003
|
|
6.7
|
|
|
$
|
17.66
|
-
|
22.92
|
|
|
20.98
|
|
636,300
|
|
6.5
|
|
536,085
|
|
6.5
|
|
|
|
|
|
|
|
|
|
|
2,824,811
|
|
|
|
2,356,503
|
|
|
|
|
| Summary of aggregate intrinsic-value of options exercised, exercisable, and vested and expected to vest |
The following table summarizes the aggregate intrinsic-value of options exercised, exercisable and vested and expected to vest (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended
|
|
|
|
|
and as of June 30,
|
|
|
|
|
2017
|
|
2016
|
|
|
Options Exercised
|
|
$
|
6,734
|
|
$
|
585
|
|
|
Options Exercisable
|
|
|
19,345
|
|
|
4,553
|
|
|
Options Vested and Expected to Vest
|
|
|
21,817
|
|
|
4,574
|
|
|
| Summary of restricted stock unit activity |
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
Weighted Average
|
|
|
|
|
Shares
|
|
Grant Date Fair Value
|
|
|
Non-vested balance at December 31, 2016
|
|
1,396,387
|
|
|
7.60
|
|
|
Awarded
|
|
781,010
|
|
|
11.23
|
|
|
Vested
|
|
(500,389)
|
|
|
7.45
|
|
|
Forfeited
|
|
(53,317)
|
|
|
8.62
|
|
|
Non-vested balance at June 30, 2017
|
|
1,623,691
|
|
|
9.36
|
|
|
| Schedule of total stock-based compensation expense classified in Statements of Operations |
Total stock-based compensation expense has been classified as follows in the accompanying Condensed Consolidated Statements of Operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
|
|
June 30,
|
|
June 30,
|
|
|
|
|
2017
|
|
2016
|
|
2017
|
|
2016
|
|
|
Cost of revenue
|
|
$
|
61
|
|
$
|
47
|
|
$
|
119
|
|
$
|
90
|
|
|
Research and development
|
|
|
1,050
|
|
|
890
|
|
|
2,179
|
|
|
1,704
|
|
|
Sales and marketing
|
|
|
884
|
|
|
600
|
|
|
1,948
|
|
|
1,109
|
|
|
General and administrative
|
|
|
914
|
|
|
590
|
|
|
1,917
|
|
|
1,047
|
|
|
Total stock-based compensation expense
|
|
$
|
2,909
|
|
$
|
2,127
|
|
$
|
6,163
|
|
$
|
3,950
|
|
|